How our attorneys can help you win an Attune Knee Lawsuit
Filing an Attune Knee lawsuit against DePuy Synthes is the only way to secure compensation for medical bills, lost time at work, pain, suffering and loss that have resulted from early DePuy knee failure, and to hold the pharmaceutical giant accountable.
Attune Knee Lawyers
The lawyers we partner with have extensive experience with knee replacement failures. Our lawyers work on contingency, meaning you never pay legal fees unless they win compensation for you. As well, they offer free, no-obligation case consultation.
We specialize in matching defective medical device lawyers with patients like you. Together, you can create a strategy that allows you to get a reasonable judgment or settlement for pain and suffering, lost wages, diminished earnings capacity and medical expenses for revision surgery. Call us today and discover the power of working with a knowledgeable, experienced attorney who is ready to fight for you—and who doesn’t get paid until you do.
Attune Knee Product Liability
Our experienced trial lawyers have a strong track record in winning product liability cases. When a large company like DePuy appears to be profiting at the expense of American consumers, they see it as their mission to pursue justice for people harmed by their product and push the company toward greater corporate responsibility rather than putting profits over people.
How Will My Case be Handled: Class Action or Individual Attune Knee Lawsuits?
DePuy knee lawsuits will not be class action lawsuits in which those who file a claim can expect only a small, symbolic settlement. Instead, our lawyers represent plaintiffs in Attune knee injury lawsuits and handle litigation in all 50 states. They believe individuals and their families who have suffered from complications due to the defective Attune Knee system may be entitled to significant compensation, from lost wages to the cost for revision surgery.
Most Attune knee claims will be consolidated in a federal Multi-District Litigation (MDL), but every complaint is handled on its own merit and compensation will be determined based on the degree of suffering of each plaintiff.
Attune Knee Lawsuits Filed
An Attune Knee injury lawsuit in Sept 2017 was filed in the Circuit Court of Tuscaloosa County, Alabama, against DePuy Synthes Sales Inc., alleging premature failure of the device. This first DePuy Synthes Attune knee lawsuit comes on the heels of a study by nine leading orthopedic surgeons and published in the Journal of Knee Surgery LINK to page XXX
In October 2017, Rocky Thompson filed an Attune knee lawsuit in Louisiana federal court against DePuy Synthes Sales Inc. (Case No. 3:17-cv-00682-SDD-RLB in the U.S. District Court for the Middle District of Louisiana. )
Three months earlier the Louisiana man underwent revision surgery to replace the defective Attune Device. According to court documents, the device failed due to a lack of bond and failure of the implant at the tibial baseplate-cement interface. Thompson is suing DePuy Synthes for “… past, present and future physical and mental pain and suffering; and past, present and future medical, hospital, rehabilitative and pharmaceutical expenses, economic damages and other related damages.”
In December 2017, a Mississippi woman filed an Attune knee lawsuit almost one year after she required revision surgery due to the alleged failure of DePuy Synthe’s Attune system.
Plaintiff Joyce Rogers was implanted with a defective Attune knee in February 2, 2015. which failed and resulted in a revision surgery in November, 2016. (Case 3:17-cv-00996-DPJ-FKB in the U.S. District Court for the Southern District of Mississippi in Northern Division.)
After the Attune knee replacement was implanted, Plaintiff Joyce Rogers began experiencing severe and persistent pain, discomfort, instability and difficulty ambulating caused by aseptic loosening, or more specifically “typical debonding” of the defective tibial baseplate. She required revision surgery “due to a lack of bond and failure of the implant at the tibial baseplate-cement interface.”
Both Thompson and Rogers lawsuits claim the following:
Failure to instruct and/or warn of the serious risk of loosening of the tibial baseplate and failure of the ATTUNE Device resulting in injuries
Failure to adequately instruct and/or warn healthcare providers, including those healthcare providers who implanted the ATTUNE Device in Plaintiff, of the serious risk of loosening of the tibial baseplate and failure of the ATTUNE Device resulting in injuries
Manufacturing, producing, promoting, creating, and/or designing the ATTUNE Device without adequately testing it
Failing to provide adequate warning of the dangers associated with the ATTUNE
The defects in designing, researching, developing, manufacturing, marketing, promoting and selling a medical device when it knew or reasonably should have known of the high risk of loosening and failure;
Defendants’ liability under the Louisiana Products Liability Act as a result of its design, development, manufacture, marketing, labeling and sale of a medical device which is defective and unreasonably dangerous;
The continued production and sale of the ATTUNE Device given the propensity of the medical device to loosen and fail at high rates resulting in subsequent surgery and injuries;
Providing inaccurate labeling and inadequate warnings and instructions with the ATTUNE Device
Both Rogers and Thompson claim their device failed due to a lack of bond and failure of the implant at the tibial baseplate-cement interface. Rogers lawsuit cites an article titled “Unusually High Rate of Early Failure of Tibial Component in ATTUNE total Knee Arthroplasty System at Implant-Cement Interface”, published in the Journal of Knee Surgery by Bonutti, et al. The authors concluded that “high rates of ATTUNE Device failures were occurring due to debonding at the tibial baseplate-cement interface.”
In its Article Assessment , DePuy attempts to discredit the article, which concluded that “high rates of ATTUNE Device failures were occurring due to debonding at the tibial baseplate-cement interface.” DePuy argues that “the article is a retrospective study with no control”. Ironically, Attune Knee was brought to market via the 501(k) process, without clinical controls.
DePuy Knee Settlements
As of January 2018, there have been no large Attune Knee replacement settlements as large groups of settlements typically occur after a few cases have been tried before a jury, and DePuy is more able to assess its financial risk. In 2013, however, DePuy agreed to pay about $2.5 billion to settle 8,000 lawsuits involving its defective ASR Hip Implant.
In Australia a judge in 2012 approved a DePuy defective knee settlement. Bloomberg reported that patients would receive payments from DePuy’s international unit ranging from $31,000 to $68,000. The lower payment covers patients who needed a new knee surgery without additional procedures; the higher amount goes to patients who faced revision surgery.
Disclaimer: Our description of your legal rights is not intended to imply that any product is defective per se. That can only be determined through a case-specific investigation and review.